ADVERTISEMENT
ICICI Direct: Sanofi India’s Margins Upbeat Despite Covid-19 Disturbances
Sanofi India’s revenue fell 11.9% year-on-year to Rs 687 crore in Q3, mainly due to the slump sale of Ankleshwar plant to Zentiva.
28 Oct 2020, 04:49 PM IST 
Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S. (Photographer Alex Flynn/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
I’m already a Subscriber Sign In
To continue reading this storySubscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
